• Explore /
  • Poster
  • / Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve vesical neoplasms: Interim analysis.

Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve vesical neoplasms: Interim analysis.

Abstract Poster

Authors

null

Alberto Saita

IRCCS - Humanitas Research Hospital, Rozzano, Italy

Alberto Saita , Rodolfo Hurle , Paola Arena , Chiara Pozzi , Miriam Cieri , Piergiuseppe Colombo , Massimo Lazzeri , Giovanni Lughezzani , Nicolò Maria Buffi , Vittorio Fasulo , Marco Paciotti , Stefano Mancon , Michela Lizier , Emanuela Morenghi , Maria Rescigno , Paolo Casale

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

2021-003751-42

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 626)

DOI

10.1200/JCO.2024.42.4_suppl.626

Abstract #

626

Poster Bd #

H11

Abstract Disclosures

Similar Posters

First Author: Massimo Lazzeri

First Author: Toshiharu Hirose

First Author: Alla Paskovaty

First Author: Minke W. Lucas